Saturday, May 21, 2022

US pharmaceutical company stockpiling its antiviral drug for monkeypox

A US pharmaceutical company says it’s in talks with European authorities seeking to stockpile its antiviral drug for monkeypox amid an "unusual international outbreak" of the virus, even though they openly admit the risk is low, if any. 

Related 

BOOM! Caught Red Hnded Planning a Monkey Pox Event 

  Quebec confirms first two cases of monkeypox; 20 other suspected cases under investigation

No comments:

Post a Comment